Table 4 Genetic diversity of eight P. vivax microsatellite loci in the study population
From: Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India
Locus | No. of alleles | Size range | Frequency of most common allele (SD) | Multiplicity of infection | H e |
|---|---|---|---|---|---|
MS2 | 10 | 188-250 | 0.281 (0.057) | 1.15 | 0.807 |
MS3 | 10 | 169-199 | 0.250 (0.055) | 1.13 | 0.852 |
MS6 | 15 | 197-269 | 0.250 (0.055) | 1.09 | 0.882 |
MS7 | 5 | 131-143 | 0.422 (0.062) | 1.01 | 0.732 |
MS9 | 15 | 137-197 | 0.226 (0.056) | 1.18 | 0.860 |
MS10 | 17 | 159-250 | 0.219 (0.052) | 1.13 | 0.906 |
MS12 | 14 | 183-311 | 0.266 (0.056) | 1.10 | 0.862 |
MS20 | 20 | 160-223 | 0.234 (0.053) | 1.14 | 0.882 |